Amphastar Pharma Purchase Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Purchase Agreement for $300,000,000 2.00% Convertible Senior Notes due 2029 between Amphastar Pharmaceuticals, Inc. and Initial Purchasers
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
NY
2023
Asset Purchase Agreement among Eli Lilly and Company, Amphastar Medication Co., LLC, and Amphastar Pharmaceuticals, Inc. dated April 21, 2023
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
DE
2023
Share Purchase Agreement between Amphastar Pharmaceuticals, Inc. and Nanjing Zhongpan, Nanjing Zhanrun, and Listening Dragon Investment Company Limited (May 6, 2021)
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
2021
Asset Purchase Agreement among Diosynth France, Amphastar France Pharmaceuticals SAS, and Schering-Plough (April 30, 2014)
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
2014
State-Owned Land Use Right Transfer Agreement between Nanjing Xingang Hi-Tech Company Limited and Amphastar Nanjing Pharmaceuticals Co., Ltd.
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
2014
Standard Offer, Agreement and Escrow Instructions for Purchase of Real Estate (Non-Residential) between Amphastar Pharmaceuticals, Inc. and Seller
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
CA
2014
Royalty Purchase Agreement between Amphastar Pharmaceuticals, Inc. and Drug Royalty USA, Inc.
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
NY
2005
Asset Sale Agreement between Amphastar Pharmaceuticals, Inc. and Organon USA Inc. (June 26, 2003)
Purchase Agreements
Amphastar Pharma
Pharmaceuticals
NJ
2005